tiprankstipranks
Trending News
More News >

Datametrex AI Extends Private Placement to Boost Healthcare Expansion

Story Highlights
Datametrex AI Extends Private Placement to Boost Healthcare Expansion

Don’t Miss TipRanks’ Half-Year Sale

An update from Datametrex AI ( (TSE:DM) ) is now available.

Datametrex AI Ltd. has announced an extension for the closing of its non-brokered private placement, expected to be finalized within two weeks, subject to TSX Venture Exchange approval. The funds raised will be used to expand the company’s healthcare product offerings, relocate two healthcare clinics, and for general working capital, without creating a new control person.

Spark’s Take on TSE:DM Stock

According to Spark, TipRanks’ AI Analyst, TSE:DM is a Neutral.

Datametrex AI Limited is currently facing significant financial challenges, marked by declining revenues, negative profitability, and high leverage. While recent strategic moves in healthcare and AI sectors, as well as a notable service order, offer potential growth avenues, the immediate financial and valuation concerns weigh heavily on the stock’s outlook. Technical indicators suggest a neutral market position, further affecting the overall stock score.

To see Spark’s full report on TSE:DM stock, click here.

More about Datametrex AI

Datametrex AI Ltd. is a leader in technology solutions, artificial intelligence, healthcare, and mobile gaming. The company focuses on enhancing operational efficiencies and business outcomes through innovative tools and solutions, setting new standards for business protocols with cutting-edge technology.

Average Trading Volume: 78,947

Technical Sentiment Signal: Sell

Current Market Cap: C$1.92M

Find detailed analytics on DM stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1